Costa Jorge C S, Neves Josiane S, de Souza Marcus V N, Siqueira Rodrigo A, Romeiro Nelilma C, Boechat Nubia, e Silva Patrícia M R, Martins Marco A
Laboratório de Síntese Orgânica, Farmanguinhos, FIOCRUZ, Rio de Janeiro, Brazil.
Bioorg Med Chem Lett. 2008 Feb 1;18(3):1162-6. doi: 10.1016/j.bmcl.2007.11.122. Epub 2007 Dec 5.
The present structure-activity relationship (SAR) study focused on chemical modifications of the structure of the local anesthetic lidocaine, and indicated analogues having reduced anesthetic potency, but with superior potency relative to the prototype in preventing anaphylactic or histamine-evoked ileum contraction. From the SAR analysis, 2-(diethylamino)-N-(trifluoromethyl-phenyl) and 2-(diethylamino)-N-(dimethyl-phenyl) acetamides were selected as the most promising compounds. New insights into the applicability of non-anesthetic lidocaine derivatives as templates in drug discovery for allergic syndromes are provided.
目前的构效关系(SAR)研究聚焦于局部麻醉药利多卡因结构的化学修饰,结果显示类似物的麻醉效力降低,但相对于原型药物,在预防过敏或组胺诱发的回肠收缩方面具有更强的效力。通过SAR分析,2-(二乙氨基)-N-(三氟甲基苯基)和2-(二乙氨基)-N-(二甲基苯基)乙酰胺被选为最具潜力的化合物。本文为非麻醉性利多卡因衍生物作为过敏综合征药物研发模板的适用性提供了新的见解。